Fenlu Zhu
- Co-authors
- Parameswaran HariCarolyn A. Keever-TaylorNirav N. ShahDina SchneiderRimas J. OrentasBoro DropulićBryon D. JohnsonTimothy S. Fenske
- Topics
- CAR-T cell therapy research (10 papers)Immune Cell Function and Interaction (4 papers)Biosimilars and Bioanalytical Methods (4 papers)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Fenlu Zhu
21 papers receiving 582 citations
Hit Papers
Peers
Comparison fields: 5 of 52
- Oncology 485
- Biomedical Engineering 197
- Molecular Biology 186
- Immunology 146
- Genetics 125
Countries citing papers authored by Fenlu Zhu
This map shows the geographic impact of Fenlu Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenlu Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenlu Zhu more than expected).
Fields of papers citing papers by Fenlu Zhu
This network shows the impact of papers produced by Fenlu Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenlu Zhu. The network helps show where Fenlu Zhu may publish in the future.
Co-authorship network of co-authors of Fenlu Zhu
This figure shows the co-authorship network connecting the top 25 collaborators of Fenlu Zhu. A scholar is included among the top collaborators of Fenlu Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenlu Zhu. Fenlu Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trialbreakdown → | 318 |
| 3 | 1 | |
| 4 | 7 | |
| 5 | 2 | |
| 6 | 32 | |
| 7 | 32 | |
| 8 | 27 | |
| 9 | 5 | |
| 10 | 87 | |
| 11 | 1 | |
| 12 | 14 | |
| 13 | 11 | |
| 14 | 4 | |
| 15 | 18 | |
| 16 | 4 | |
| 17 | 4 | |
| 18 | 5 | |
| 19 | 13 | |
| 20 | A Preliminary Study on Macaca Mulatta Infected by Intrahepatic Injection of GHV-C/HGV RNA Transcripts Produced in vitro | 3 |
About Fenlu Zhu
Fenlu Zhu is a scholar working on Hepatology, Immunology and Oncology, having authored 21 papers that have together received 593 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Immune Cell Function and Interaction (4 papers) and Biosimilars and Bioanalytical Methods (4 papers). The work is most often cited by research in Oncology (485 citations), Immunology (146 citations) and Biomedical Engineering (197 citations). Fenlu Zhu has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Parameswaran Hari, Carolyn A. Keever-Taylor, Nirav N. Shah, Dina Schneider, Rimas J. Orentas, Boro Dropulić, Bryon D. Johnson, Timothy S. Fenske, Mehdi Hamadani and Winfried Krueger. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.